BRYAN SANDOVAL: Open Payments
NPI 1902450620 · WHITTIER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,447 in 113 payments from 14 companies in 2025. Trend: 2023 $18 · 2024 $60 · 2025 $2,447
Food & beverage: $2,348Education: $99
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 20 | $350 |
| LEO Pharma Inc. | 12 | $304 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $298 |
| Janssen Biotech, Inc. | 8 | $233 |
| Novartis Pharmaceuticals Corporation | 14 | $232 |
| UCB, Inc. | 5 | $227 |
| Amgen Inc. | 16 | $179 |
| Arcutis Biotherapeutics, Inc. | 9 | $154 |
| Incyte Corporation | 6 | $146 |
| Paratek Pharmaceuticals, Inc. | 5 | $93 |
Products named: NEMLUVIO, ADBRY, TREMFYA, Bimzelx, COSENTYX, Winlevi, OTEZLA, Zoryve.
Industry payments across CA — which companies pay providers there.
